{"id":"https://openalex.org/W1533844751","doi":null,"title":"Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis.","display_name":"Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis.","publication_year":2000,"publication_date":"2000-03-01","ids":{"openalex":"https://openalex.org/W1533844751","mag":"1533844751","pmid":"https://pubmed.ncbi.nlm.nih.gov/10705306"},"language":"en","primary_location":{"id":"pmid:10705306","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10705306","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European cytokine network","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039182895","display_name":"S Giosu\u00e8","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091493","display_name":"Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani","ror":"https://ror.org/00kv87w35","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210091493","https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I4210153126","display_name":"Istituti di Ricovero e Cura a Carattere Scientifico","ror":"https://ror.org/04tfzc498","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"S Giosu\u00e8","raw_affiliation_strings":["Istituto Lazzaro Spallanzani, IRCCS, Clinica Malattie dell'Apparato Respiratorio, Via Portuense 292, 00149 Roma (Italia). giosue.s@flashnet.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Lazzaro Spallanzani, IRCCS, Clinica Malattie dell'Apparato Respiratorio, Via Portuense 292, 00149 Roma (Italia). giosue.s@flashnet.it","institution_ids":["https://openalex.org/I4210091493","https://openalex.org/I4210153126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012696315","display_name":"M Casarini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Casarini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111418496","display_name":"F. Ameglio","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Ameglio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059050333","display_name":"PROFETA ZANGRILLI","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Zangrilli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050761946","display_name":"Marco Palla","orcid":"https://orcid.org/0000-0001-8901-0974","observed_orcids":["https://orcid.org/0000-0001-8901-0974"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Palla","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111979205","display_name":"Alfonso Maria Altieri","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A M Altieri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5069721177","display_name":"A Bisetti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Bisetti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2456,"has_fulltext":false,"cited_by_count":74,"citation_normalized_percentile":{"value":0.78212369,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"11","issue":"1","first_page":"99","last_page":"104"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11381","display_name":"Infectious Diseases and Tuberculosis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11316","display_name":"Mycobacterium research and diagnosis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multidrug-resistant-tuberculosis","display_name":"multidrug-resistant tuberculosis","score":0.8029999732971191},{"id":"https://openalex.org/keywords/pulmonary-tuberculosis","display_name":"pulmonary tuberculosis","score":0.9120000004768372},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.8159999847412109},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.9729999899864197},{"id":"https://openalex.org/keywords/nonresponders","display_name":"non-responders","score":0.7250000238418579},{"id":"https://openalex.org/keywords/sputum-culture","display_name":"sputum culture","score":0.7089999914169312},{"id":"https://openalex.org/keywords/mycobacterium-tuberculosis","display_name":"Mycobacterium tuberculosis","score":0.8320000171661377},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8550000190734863},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.8320000171661377},{"id":"https://openalex.org/keywords/directly-observed-therapy","display_name":"directly observed therapy","score":0.7170000076293945}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7884430885314941},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.7192609906196594},{"id":"https://openalex.org/C2776301714","wikidata":"https://www.wikidata.org/wiki/Q259346","display_name":"Sputum","level":3,"score":0.6815608143806458},{"id":"https://openalex.org/C2909923361","wikidata":"https://www.wikidata.org/wiki/Q2339584","display_name":"Directly Observed Therapy","level":3,"score":0.5880112648010254},{"id":"https://openalex.org/C2780841837","wikidata":"https://www.wikidata.org/wiki/Q24741149","display_name":"Interferon gamma","level":3,"score":0.587373673915863},{"id":"https://openalex.org/C2777975735","wikidata":"https://www.wikidata.org/wiki/Q130971","display_name":"Mycobacterium tuberculosis","level":3,"score":0.5840564370155334},{"id":"https://openalex.org/C82085835","wikidata":"https://www.wikidata.org/wiki/Q16142045","display_name":"Aerosolization","level":3,"score":0.5510712265968323},{"id":"https://openalex.org/C2777768864","wikidata":"https://www.wikidata.org/wiki/Q18387898","display_name":"Culture conversion","level":4,"score":0.5278829336166382},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.5010089874267578},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4809660017490387},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.47662317752838135},{"id":"https://openalex.org/C2908628106","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Pulmonary tuberculosis","level":3,"score":0.4454897344112396},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.43300461769104004},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4261944890022278},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.3375954031944275},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.3171290159225464},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2798454165458679},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2172020971775055},{"id":"https://openalex.org/C2776954882","wikidata":"https://www.wikidata.org/wiki/Q840343","display_name":"Inhalation","level":2,"score":0.10236665606498718},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.09549301862716675},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000336","descriptor_name":"Aerosols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001992","descriptor_name":"Bronchoalveolar Lavage Fluid","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007378","descriptor_name":"Interleukins","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009169","descriptor_name":"Mycobacterium tuberculosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009169","descriptor_name":"Mycobacterium tuberculosis","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D013183","descriptor_name":"Sputum","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D014397","descriptor_name":"Tuberculosis, Pulmonary","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018432","descriptor_name":"Drug Resistance, Multiple","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:10705306","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10705306","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European cytokine network","raw_type":"Clinical Trial"},{"id":"mag:1533844751","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10705306","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2110042355","https://openalex.org/W2108374918","https://openalex.org/W2169794251","https://openalex.org/W7098057483","https://openalex.org/W7097665397","https://openalex.org/W2282970063","https://openalex.org/W2425719923","https://openalex.org/W2120055165","https://openalex.org/W4387012090","https://openalex.org/W2152640762"],"abstract_inverted_index":{"Multi-drug-resistant":[0],"tuberculosis":[1,30,218],"(MDR-TB)":[2],"has":[3,48],"emerged":[4],"as":[5,139,316,318],"an":[6,127],"obstacle":[7],"to":[8,86,119,146],"the":[9,88,101,155,166,175,179,182,187,209,213,228,235,250,274,285,309],"control":[10],"of":[11,74,82,103,109,181,208,216,232,239,252,300],"tuberculosis.":[12,105],"Recent":[13],"data":[14,332],"however,":[15,351],"suggest":[16,333],"that":[17,51,90,212,334],"interferon-(IFN)-gamma":[18],"and":[19,35,71,202,349],"IFN-alpha":[20,62,128,153,183,204,240,336],"may":[21,56,76,99,337],"improve":[22,100],"disease":[23],"evolution":[24],"in":[25,257,284,308,319,327],"subjects":[26],"affected":[27],"with":[28,95,165,178,295,345],"pulmonary":[29,104],"caused":[31],"by":[32,67],"multi-resistant":[33],"(IFN-gamma)":[34],"sensitive":[36],"(IFN-alpha)":[37],"strains.":[38],"The":[39,80,206],"mechanisms":[40],"involved":[41],"are":[42],"not":[43],"known,":[44],"even":[45],"though":[46],"it":[47],"been":[49],"reported":[50],"IFN-gamma-secreting":[52],"CD4+":[53,68],"Th":[54,69],"cells":[55],"possess":[57],"antitubercular":[58,97,123],"effects.":[59],"In":[60],"addition,":[61],"can":[63],"induce":[64],"IFN-gamma":[65],"secretion":[66],"cells,":[70],"both":[72],"types":[73],"IFN":[75],"stimulate":[77],"macrophage":[78],"activities.":[79],"aim":[81],"this":[83],"study":[84,176,275],"was":[85,260,290,314],"explore":[87],"possibility":[89],"aerosolized":[91,335],"IFN-alpha,":[92,301],"administered":[93],"concomitantly":[94],"conventional":[96],"chemotherapy,":[98],"course":[102],"After":[106,152,249,297],"six":[107,163],"months":[108,138,164,231,238],"directly":[110],"observed":[111,261,291],"therapy":[112,124,342],"(DOT),":[113],"seven":[114],"patients":[115,156,243,272,344],"who":[116],"were":[117,125,144,157,171,189,199,324],"non-responders":[118],"a":[120,134,161,254,278,302,339],"second":[121],"line":[122],"given":[126],"aerosol":[129],"(3":[130],"MU,":[131],"three":[132],"times":[133],"week)":[135],"for":[136,160,270,343],"two":[137,149],"adjunctive":[140,293,341],"therapy.":[141],"All":[142],"strains":[143],"resistant":[145],"at":[147],"least":[148],"first-line":[150],"drugs.":[151],"administration,":[154,241],"followed":[158],"up":[159],"further":[162,353],"same":[167],"DOT.":[168,233],"Sputum":[169,266],"samples":[170],"collected":[172],"monthly":[173],"during":[174,227],"period,":[177,185,276],"exception":[180],"administration":[184,299],"when":[186],"observations":[188],"performed":[190,200],"weekly.":[191],"High":[192],"resolution":[193],"computed":[194],"tomography":[195],"(HRCT)":[196],"chest":[197],"scans":[198,323],"before":[201],"after":[203,292],"inhalations.":[205],"analysis":[207],"results":[210],"showed":[211],"mean":[214],"number":[215,259,287,311],"Mycobacterium":[217],"(Mt)":[219],"had":[220],"remained":[221,268],"statistically":[222],"unchanged":[223],"(p":[224,246,262,281,305],"=":[225,247,263,282,306],"0.80)":[226],"first":[229],"6":[230],"During":[234],"following":[236],"2":[237],"5":[242],"became":[244],"negative":[245],"0.02).":[248],"end":[251],"treatment":[253,294],"progressive":[255],"increase":[256,304],"Mt":[258,320],"0.":[264],"02).":[265],"cultures":[267],"positive":[269],"all":[271,328],"throughout":[273],"although":[277],"significant":[279,303],"decrease":[280],"0.02)":[283],"colony":[286,310],"per":[288,312],"culture":[289,313],"IFN-alpha.":[296],"stopping":[298],"0.03)":[307],"noted":[315],"well":[317],"numbers.":[321],"HRCT":[322],"slightly":[325],"improved":[326],"patients.":[329],"These":[330],"preliminary":[331],"be":[338],"promising":[340],"MDR-TB.":[346],"Optimal":[347],"doses":[348],"schedules":[350],"require":[352],"studies.":[354]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}